News

Johns Hopkins finds positive result in COVID-19 ARDS treated patients with Cellenkos' Cord Blood cells

Physician-investigators at the Johns Hopkins University Hospital found promising data of treatment of COVID-19 induced ARDS with allogeneic, cord blood derived T-regulatory (Treg) cell therapy

Read More

Jul 07, 2020

By : Team ABLE

Noted clinical scientist Gagandeep Kang quits as executive director of THSTI

A noted name in the field of epidemiology and vaccinology, she was instrumental in building the national rotavirus and typhoid surveillance networks.

Read More

Jul 07, 2020

By : Team ABLE

AstraZeneca’s Dapagliflozin gets approval for treatment of Heart Failure patients with reduced ejection fraction

This is the first in class SGLT-2 inhibitor drug approved for the treatment of HFrEF and is the first drug proven to significantly reduce the risk of Cardiovascular death

Read More

Jul 07, 2020

By : Team ABLE

DyCM launches 6 innovative products developed by Bengaluru startups to tackle COVID-19

In a major boost to tackle Covid-19 in Karnataka, 6 products that are being imported so far, have been developed locally by startups supported by the Government.

Read More

Jul 07, 2020

By : Team ABLE

Dr Reddy’s Labs, ABLE member, to make Favipiravir with Fujifilm Toyoma tie-up for India, global markets treat COVID-19

A Tripartite Licensing Agreement was concluded between Fujifilm Toyama, Dr. Reddy's Laboratories and GRA, concerning the development, manufacture and sales of Favipiravir ( Avigan) tablets used to treat COVID-19 patients

Read More

Jul 02, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights